Vantage Investment Partners, LLC Novo Nordisk A S Transaction History

Vantage Investment Partners, LLC

$1.32 Billion
Q2 2025

A detailed history of Vantage Investment Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Vantage Investment Partners, LLC holds 454,124 shares of NVO stock, worth $25.5 Million. This represents 2.38% of its overall portfolio holdings.

Number of Shares

454,124

Previous 459,687 1.21%

Holding current value

$25.5 Million

Previous $31.9 Million 1.81%

% of portfolio

2.38%

Previous 2.76%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 22, 2025	SELL	$58.08 - $81.05 $323,099 - $450,881	-5,563 Reduced 1.21%	454,124 $31.3 Million
Q1 2025 Apr 22, 2025	SELL	$69.3 - $90.95 $8.37 Million - $11 Million	-120,730 Reduced 20.8%	459,687 $31.9 Million
Q4 2024 Jan 22, 2025	BUY	$85.0 - $120.04 $12.9 Million - $18.2 Million	151,620 Added 35.36%	580,417 $49.9 Million
Q3 2024 Nov 04, 2024	SELL	$119.07 - $145.42 $12.6 Million - $15.4 Million	-105,974 Reduced 19.82%	428,797 $51.1 Million
Q2 2024 Jul 29, 2024	SELL	$122.71 - $146.91 $7.98 Million - $9.55 Million	-65,020 Reduced 10.84%	534,771 $76.3 Million
Q1 2024 Apr 30, 2024	BUY	$102.11 - $135.92 $11.9 Million - $15.9 Million	116,681 Added 24.15%	599,791 $77 Million
Q4 2023 Jan 31, 2024	BUY	$87.78 - $105.45 $15.4 Million - $18.5 Million	175,378 Added 56.99%	483,110 $50 Million
Q3 2023 Oct 25, 2023	BUY	$90.94 - $199.54 $13.3 Million - $29.2 Million	146,421 Added 90.77%	307,732 $28 Million
Q2 2023 Jul 24, 2023	BUY	$155.98 - $172.65 $1.07 Million - $1.19 Million	6,864 Added 4.44%	161,311 $26.1 Million
Q1 2023 Apr 18, 2023	SELL	$132.34 - $159.14 $3.87 Million - $4.65 Million	-29,250 Reduced 15.92%	154,447 $24.4 Million
Q4 2022 Jan 27, 2023	SELL	$102.55 - $135.33 $1.66 Million - $2.2 Million	-16,227 Reduced 8.12%	183,697 $24.9 Million
Q3 2022 Oct 18, 2022	SELL	$95.28 - $116.93 $27.6 Million - $33.8 Million	-289,187 Reduced 59.13%	199,924 $19.9 Million
Q1 2022 Apr 22, 2022	BUY	$93.1 - $112.54 $45.5 Million - $55 Million	489,111 New	489,111 $54.3 Million

Others Institutions Holding NVO

# of Institutions

1,729

Shares Held

313M

Call Options Held

13.7M

Put Options Held

19.7M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $127B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vantage Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vantage Investment Partners, LLC with notifications on news.

Account

Vantage Investment Partners, LLC Novo Nordisk A S Transaction History